TUG1 and chronic kidney disease: The present study has significant implications in developing future therapeutics of CKD and suggests that KP1, a peptide with 30 amino acids, is able to induce both mKlotho and sKlotho expression via epigenetic regulation mediated by miR-223-3p and lncRNA-TUG1.